OpenEvidence vs TREWS (Targeted Real-Time Early Warning System)

OpenEvidence is designed for individual clinicians, offering a clean and responsive web application and native mobile apps with features like Home Screen widgets for fast access. Its focus on quick, cited answers to clinical questions makes it a high-speed literature and evidence lookup tool. While TREWS integrates into EHRs and provides real-time alerts, OpenEvidence's direct-to-clinician approach and mobile accessibility suggest a broader and more immediate individual usability.

TREWS has demonstrated a significant impact on patient outcomes, with studies showing an 18% reduction in in-hospital mortality for sepsis patients when alerts were confirmed by a provider within 3 hours. It also led to earlier antibiotic administration and reduced length of stay. While OpenEvidence provides evidence-based answers and aids in documentation, its clinical impact is more focused on supporting physician decisions and research rather than directly improving patient mortality rates.

OpenEvidence is free for verified U.S. healthcare professionals, making it highly accessible and a strong value proposition for individual clinicians. Its revenue model is supported by pharmaceutical advertising, which is transparently displayed. TREWS, on the other hand, is an enterprise-level solution with custom pricing, typically for hospitals and health systems, making it a significant institutional investment.

Both tools demonstrate strong enterprise readiness through EHR integration. OpenEvidence integrates with Epic and is embedded at Mount Sinai Health System. TREWS also integrates with major EHRs like Epic and Cerner and has been deployed in multiple hospitals, monitoring hundreds of thousands of patients. Both are HIPAA compliant and have BAA agreements, indicating their suitability for enterprise deployment.

OpenEvidence innovates by providing AI-powered natural language question answering grounded in peer-reviewed medical literature, offering a novel approach to clinical decision support and documentation. TREWS demonstrates innovation through its adaptive AI that learns from clinician feedback and its ability to analyze multi-modal patient data for real-time, early-warning alerts for critical conditions like sepsis. Both leverage advanced AI to address significant healthcare challenges in unique ways.

The provided information does not offer specific details about the depth or breadth of support and documentation for either OpenEvidence or TREWS. While both are sophisticated platforms, without explicit information on their support channels, user guides, or training programs, it is not possible to definitively pick a winner in this dimension.